New York, USA - October 27, 2022 - Since the initiation of 2022, seeing the return of in-person networking conferences, Creative Biolabs has been enthusiastically involved in various industry affairs. Even though it's almost halfway through the Q4 of 2022, it is still considering additional events to its agenda in November and December. Last week, Creative Biolabs announced its participation in an intensive industry event - Scientist.com's Vendor Discovery Day, on November 2, 2022.
"This affair is hosted by one of our valued partners, Scientist.com, that we've been collaborated with for years," according to a scientist, "and we're happy to see that they are holding networking affairs that provide opportunities for CROs like us to communicate face-to-face with researchers from renowned pharmaceutical companies."
Creative Biolabs is well known for its versatile strategies in the development of antibody-based therapies, which, through high-end technology platforms, achieve the design, engineering, and production of diverse antibody modalities, including but not limited to mAbs, sdAbs, and bsAbs. What is worth mentioning is its exclusive Magic™ platform that was established to afford protein products, thus meeting the needs for diverse research objectives, like immunogen and delivery vehicles.
During the Vendor Discovery Day, there is a high chance of previewing the exclusive of Creative Biolabs, De Novo Antibody Sequencing, which is based on the proprietary Database Assisted Shotgun Sequencing (DASS) technology. It can achieve 100% coverage of desired regions with excellent accuracy, preferentially differentiating leucine and isoleucine.
"This time, researchers who'll come by are from Teva mainly," added the scientist, "and we're willing to learn about their progress and discover how Creative Biolabs can play a part in the projects."
Learn more about Creative Biolabs' event arrangements at https://events.creative-biolabs.com.
About
Creative Biolabs is a CRO devoted to new antibody and immunotherapy discovery, providing one-stop solutions supportive of the entire pipeline. Years of exploration in the industry has won Creative Biolabs a good reputation in the industry. Bearing the aim to showcase capabilities and seek partnership opportunities, a team of scientists from Creative Biolabs embarked on the journey to global networking conferences within their scope of specialties. In December 2022, scientists from Creative Biolabs will also show up at the #1 antibody engineering conference - Antibody Engineering & Therapeutics US 2022.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com
